Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan;172(1):112-22.
doi: 10.2353/ajpath.2008.070564. Epub 2007 Dec 13.

Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases

Affiliations

Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases

Calogera M Simonaro et al. Am J Pathol. 2008 Jan.

Abstract

We have previously shown that glycosaminoglycan (GAG) storage in animal models of the mucopolysaccharidoses (MPS) leads to inflammation and apoptosis within cartilage. We have now extended these findings to synovial tissue and further explored the mechanism underlying GAG-mediated disease. Analysis of MPS rats, cats, and/or dogs revealed that MPS synovial fibroblasts and fluid displayed elevated expression of numerous inflammatory molecules, including several proteins important for lipopolysaccharide signaling (eg, Toll-like receptor 4 and lipoprotein-binding protein). The expression of tumor necrosis factor, in particular, was elevated up to 50-fold, leading to up-regulation of the osteoclast survival factor, receptor activator of nuclear factor-kappaB ligand, and the appearance of multinucleated osteoclast-like cells in the MPS bone marrow. Treatment of normal synovial fibroblasts with GAGs also led to production of the prosurvival lipid sphingosine-1-phosphate, resulting in enhanced cell proliferation, consistent with the hyperplastic synovial tissue observed in MPS patients. In contrast, GAG treatment of normal chondrocytes led to production of the proapoptotic lipid ceramide, confirming the enhanced cell death we had previously observed in MPS cartilage. These findings have important implications for the pathogenesis and treatment of MPS and have further defined the mechanism of GAG-stimulated disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A: Detection of the TLR4, 192-kDa heterodimer; lipopolysaccharide-binding protein (LBP), 57-kDa monomer; adaptor molecule MyD88, 30-kDa monomer; and protein kinase C-α (PKC-α), 82-kDa monomer (as a loading control) by Western blot analysis in normal and MPS VI rat FLSs and chondrocytes. An equal number of cells (7.2 × 105 FLSs and 1.6 × 106 chondrocytes) were used to prepare the extracts, and an equal volume (20 μl) was loaded into each lane. B: TLR4 immunostaining in 12-month-old normal and MPS VI rat articular cartilage. Scale bars = 10 μm.
Figure 2
Figure 2
Effects of dermatan sulfate (DS) on ceramide and S1P levels in rat chondrocytes and FLSs. A: Normal chondrocytes (filled circles) and FLSs (open circles) were grown in standard culture media containing 100 μg/ml of DS for 120 minutes and ceramide levels were determined in cell lysates. B: Normal and MPS VI rat FLSs were grown in standard culture media for 48 hours and S1P levels were determined in cell lysates. Mean (n = 4) ± SEM. *P < 0.001. C: Proliferation studies in FLSs from 1-year-old normal (open boxes) and MPS VI rats (filled boxes). Cells were grown for 48 hours and the proliferation rates were determined. Data represent median values obtained from four independent experiments. MPS VI rat FLSs showed a greater than twofold increase. *P < 0.001.
Figure 3
Figure 3
MIP-1α immunostaining in 12-month-old normal and MPS VII dog bone marrow and synovial membrane. A and C: Normal bone marrow and synovial membrane. B and D: MPS VII bone marrow and synovial membrane showing MIP-1α-positive (arrows) macrophages. Scale bars = 50 μm.
Figure 4
Figure 4
TNF-α and IL-1β levels in synovial fluid from normal and MPS VII dogs, and MPS VI rat FLSs. A: TNF-α and IL-1β concentrations were determined in serum-free FLS-conditioned culture media from MPS VI rats collected after 48 hours. Normal controls are shown by open boxes, and filled boxes represent MPS VI animals. B: Synovial fluid from normal (open boxes) and MPS VII dogs (filled boxes). Mean (n = 4) ± SEM. *P < 0.001.
Figure 5
Figure 5
MMP expression in MPS VI rats. A: MMP-13 immunostaining in age-matched (12-month) normal and MPS VI rat synovial membranes. B: MMP-13 and MMP-1 RNA expression in rat FLSs. PCR analysis for MMP-1 and -13 was performed using mRNA obtained from FLS cultures. C: MMP-13 released into FLS-conditioned, serum-free culture supernatants collected after 48 hours. Mean (n = 4) ± SEM. *P < 0.001. Scale bars = 50 μm.
Figure 6
Figure 6
TRAP-positive multinuclear cells (multinucleated osteoclast-like cells) in bone marrow cultures from MPS VI rats. A: Bone marrow cultures from normal 12-month-old rats. B: Age-matched MPS VI bone marrow cultures showing TRAP-positive multinucleated osteoclast-like cells (arrows). TRAP was used as a marker for osteoclasts. Scale bars = 50 μm.
Figure 7
Figure 7
RANKL expression in 12-month-old rat MPS VI chondrocytes and FLSs. A: PCR analysis was performed using mRNA obtained from chondrocyte and FLS cultures. B: RANKL concentrations were determined in serum-free FLS culture supernatants after 48 hours. Mean (n = 4) ± SEM. *P < 0.001.

References

    1. Neufeld EF, Muenzer J. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill,; 2001:pp 3421–3452.
    1. Simonaro CM, Haskins ME, Schuchman EH. Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab Invest. 2001;81:1319–1328. - PubMed
    1. Simonaro CM, D’Angelo M, Haskins ME, Schuchman EH. Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. Pediatr Res. 2005;57:701–707. - PubMed
    1. De Vries-Bouwstra JK, Goekoop-Ruiterman YP, Wesoly J, Hulsmans HJ, de Craen AJ, Breedveld FC, Dijkmans BA, Allaart CF, Huizinga TW: Ex vivo IL1 receptor antagonist production upon LPS stimulation is associated with development of RA and with greater progression of joint damage. Ann Rheum Dis 2007, Jan 12:[Epub ahead of print] - PMC - PubMed
    1. Goldring SR. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol. 2002;4:406–410. - PubMed

Publication types